Espina, Zyruz Ryl M.

HRN: 29-33-14  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2026
OXACILLIN 500MG (VIAL)
07/16/2026
07/23/2026
IV
320mg
Q6hours
T/c Cellulitis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: